1. A4.2 IL4–10 synerkine for the treatment of osteoarthritis. (13th February 2015) Authors: Steen-Louws, C; Pustjens, MF; Mastbergen, SC; Hack, CE; van Roon, JAG; Lafeber, FPJG Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0061 35sulphate incorporation assay as a new tool for measuring early cartilage degradation following blood exposure in vitro and in vivo in f8 ko rats. (15th June 2017) Authors: Pulles, AE; Christensen, KR; Coeleveld, K; Kjelgaard-Hansen, M; Schutgens, RE; Lafeber, FP; Roepstorff, K; Mastbergen, SC Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1068 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0818 Personalized articulating joint distraction for treatment of tibiofemoral osteoarthritis: clinical feasibility. (15th June 2017) Authors: Struik, T; Custers, RJ; Besselink, NJ; Jaspers, JE; Marijnissen, AK; Lafeber, FP; Mastbergen, SC Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0008 Effects of the human il4-10 fusion protein in the canine groove model of osteoarthritis. (15th June 2017) Authors: Helvoort, EM Van; Popov-Celeketic, J; Coeleveld, K; Tryfonidou, MA; Lafeber, FP; Mastbergen, SC Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Intrinsic joint tissue repair by joint distraction. Issue 1 (2013) Authors: Wiegant, K; Heerwaarden, RJ van; Roermund, PM van; Mastbergen, SC Journal: OA arthritis Issue: Volume 1:Issue 1(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0508 Lack of a clear disease modifying activity of celecoxib in treatment of end-stage knee osteoarthritis: a randomized observer blinded clinical trial. (15th June 2017) Authors: Helvoort, EM Van; Coeleveld, K; Boer, TN de; Huisman, AM; Polak, AA; Bijlsma, JWJ; Laar, JM van; Lafeber, FJPG; Mastbergen, SC Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 968 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗